stockrow
Saturday 7 November 2026
Export IMA’s income statement to Excel — free account
ImageneBio, Inc.
ImageneBio, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $800,000.00, down 77.1% from fiscal 2024.
- Revenue
- −60.1%
- EPS
- +85.9%
- Free cash flow
- +23.8%
Quarter to June 2026, against a year earlier
4.11
0.06
−1.44%
Follow IMA
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
12.79 | 12.05 | 17.67 | 20.71 | |
Current Ratio |
13.24 | 12.49 | 18.39 | 21.47 | |
Net Debt/EBITDA |
5.42 | 16.96 | 9.84 | 11.73 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.84 | 1.04 | 1.39 | 0.89 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.52) | (1.48) | (1.32) | (0.56) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(2.52) | (1.48) | (1.32) | (0.56) | |
Cash per Share |
16.72 | 27.79 | 10.45 | 8.42 | |
Shareholders Equity per Share |
16.40 | 27.33 | 11.00 | 8.79 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.40 | 27.33 | 11.00 | 8.79 | |
Free Cash Flow |
(21.49) | (7.22) | (14.80) | (9.07) | |
Working Capital |
136.39 | 129.05 | 115.37 | 134.54 | |
Net Current Asset Value |
126.49 | 120.45 | 108.65 | 131.14 | |
| Other line items | |||||
Average Payables |
1.81 | 3.36 | 0.69 | 0.74 | |
Average Assets |
154.93 | 84.45 | 133.76 | 139.11 | |
Average Common Equity |
137.03 | (23.20) | 120.79 | 128.99 |
Columns are period end dates · fundamentals updated 26 Oct 2026